Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma.
about
Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developmentsComprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.Control of nuclear-cytoplasmic shuttling of Ankrd54 by PKCδ.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.The Molecular Basis for Specificity at the Level of the Protein Kinase a Catalytic Subunit
P2860
Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhanced cAMP-stimulated prote ...... llar hepatocellular carcinoma.
@en
Enhanced cAMP-stimulated prote ...... llar hepatocellular carcinoma.
@nl
type
label
Enhanced cAMP-stimulated prote ...... llar hepatocellular carcinoma.
@en
Enhanced cAMP-stimulated prote ...... llar hepatocellular carcinoma.
@nl
prefLabel
Enhanced cAMP-stimulated prote ...... llar hepatocellular carcinoma.
@en
Enhanced cAMP-stimulated prote ...... llar hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Enhanced cAMP-stimulated prote ...... llar hepatocellular carcinoma.
@en
P2093
Bret Samelson
G Stanley McKnight
Heidi L Kenerson
John D Scott
Kevin M Riggle
Kimberly J Riehle
Machiko Kazami
Raymond S Yeung
Renay Bauer
Rigney Turnham
P2860
P2888
P304
P356
10.1038/PR.2016.36
P407
P577
2016-03-08T00:00:00Z